IQVIA (United States)
In research, IQVIA (United States) stands highest in Medicine (#3,723 of 10,443 worldwide) and Health Sciences (#4,943 of 11,982 worldwide), 2022–2025. Relative to its size it is most specialised in Economics and Econometrics and Economics, Econometrics and Finance — Economics and Econometrics is 7.2× its share of world research.
- World rank, 2022–2025
- #9,752 of 28,054 · #8,331 all time
- Rank in United States
- #1,302 of 4,192
- Research works
- 2.1k ▼ 25% vs 2013–17
- Citations
- 37k 17.9 per fractional work
- Top-10% rate
- 11.4% record average 16.5%
- Open access
- 27% world 28%
What is IQVIA (United States) known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #3,723 of 10,443 | 12.2% | 157 | #2082 | |
| Health SciencesDomain | #4,943 of 11,982 | 12.1% | 171 | #2503 |
Each strip is that field’s whole ranked pool, with the notch where IQVIA (United States) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
What does IQVIA (United States) specialise in?
Where its research is concentrated relative to its size: Economics and Econometrics takes 7.2× the share of its output that it takes of world research.
- Economics and EconometricsSubfield · 33.6 works7.2×
- Economics, Econometrics and FinanceField · 33.9 works5.4×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Economics, Econometrics and Finance, 5.4×. Every wedge is a field page.
- Economics, Econometrics and Finance 5.4×
- Immunology and Microbiology 3.2×
- Medicine 2.8×
- Pharmacology, Toxicology and Pharmaceutics 2.5×
- Chemistry 2.2×
- Health Professions 1.6×
- Biochemistry, Genetics and Molecular Biology 1.4×
- Mathematics 1.3×
- Chemical Engineering 1.0×
- Decision Sciences 0.7×
- Psychology 0.6×
- Dentistry 0.6×
- Neuroscience 0.5×
- Computer Science 0.5×
- Nursing 0.4×
- Veterinary 0.2×
- Agricultural and Biological Sciences 0.2×
- Energy 0.2×
- Social Sciences 0.2×
- Environmental Science 0.1×
- Engineering 0.1×
- Business, Management and Accounting 0.1×
- Arts and Humanities 0.1×
- Materials Science 0.0×
- Physics and Astronomy 0.0×
- Earth and Planetary Sciences 0.0×
Who are the top researchers at IQVIA (United States)?
Ranked on the composite score, James D. Wilkinson, G. Alan Marlatt and Kenneth A. Wallston lead among researchers whose main affiliation is IQVIA (United States).
- 1 James D. Wilkinson United States · #4,280 worldwide 1.1k citations · 71 works
- 2 G. Alan Marlatt United States · #7,807 worldwide 927 citations · 109 works
- 3 Kenneth A. Wallston United States · #14,122 worldwide 375 citations · 72 works
- 4 Peter A. Hall United States · #15,512 worldwide 1.3k citations · 182 works
- 5 Francine Kaufman United States · #16,081 worldwide 394 citations · 99 works
- 6 Bonnie Bruce United States · #16,748 worldwide 698 citations · 122 works
- 7 Martica H. Hall United States · #17,336 worldwide 579 citations · 110 works
- 8 Crystal L. Park United States · #23,872 worldwide 1k citations · 160 works
- 9 Judith A. Hall United States · #27,988 worldwide 551 citations · 96 works
- 10 Ronald Goldberg United States · #31,105 worldwide 437 citations · 85 works
Which keywords describe research at IQVIA (United States)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Quality of Life, Epidemiology, Economic Evaluation, Cost-effectiveness Analysis, Health Utility Measures, Clinical Trials, Targeted Therapy and Treatment.
- Interventions
- Biomedical Literature
- Transition Metal Catalysis
- Medication Adherence
- Chronic Disease Management
- Financial Toxicity
- ACE2 Receptor
- Rituximab
- SARS-CoV-2
- Drug Development Costs
- Prognostic Factors
- Management
- Cardiovascular Disease
- Targeted Therapy
- Chemotherapy
- Healthcare
- Inflammation
- Clinical Trials
- Cost-effectiveness Analysis
- Quality of Life
- Epidemiology
- Economic Evaluation
- Health Utility Measures
- Treatment
- Pandemic
- Diagnosis
- Immunotherapy
- Biomarkers
- Immune Response
- Pharmaceutical Industry
- Vaccine
- Generic Drugs
- Lymphoma
- Treatment Guidelines
- Cost of Care
- Data Integration
- Genomic Profiling
- Text Mining
- Monoclonal Antibodies
- Biomedical Ontologies
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology35▲ 3.0×83 topics
- Quality of Life27▲ 6.4×28 topics
- Economic Evaluation19▲ 52×2 topics
- Cost-effectiveness Analysis18▲ 74×1 topic
- Health Utility Measures18▲ 74×1 topic
- Clinical Trials17▲ 8.6×16 topics
- Treatment11▲ 3.2×26 topics
- Inflammation11▲ 1.84×42 topics
- Pandemic10▲ 3.1×6 topics
- Healthcare10▲ 2.9×9 topics
- Diagnosis10▲ 3.5×21 topics
- Chemotherapy9▲ 4.3×19 topics
- Immunotherapy8▲ 4.0×17 topics
- Targeted Therapy8▲ 12×4 topics
- Biomarkers8▲ 3.9×11 topics
- Cardiovascular Disease8▲ 2.4×23 topics
- Immune Response7▲ 4.2×13 topics
- Management7▲ 3.0×18 topics
- Pharmaceutical Industry7▲ 62×2 topics
- Prognostic Factors7▲ 5.2×10 topics
- Vaccine7▲ 5.6×9 topics
- Drug Development Costs6▲ 78×1 topic
- Generic Drugs6▲ 78×1 topic
- SARS-CoV-26▲ 6.3×5 topics
- Lymphoma6▲ 12×4 topics
- Rituximab5▲ 12×4 topics
- Treatment Guidelines5▲ 8.2×6 topics
- ACE2 Receptor5▲ 7.0×3 topics
- Cost of Care5▲ 56×1 topic
- Financial Toxicity5▲ 56×1 topic
- Data Integration5▲ 9.8×3 topics
- Chronic Disease Management5▲ 8.3×5 topics
- Genomic Profiling5▲ 15×2 topics
- Medication Adherence5▲ 29×2 topics
- Text Mining5▲ 12×2 topics
- Transition Metal Catalysis4▲ 18×2 topics
- Monoclonal Antibodies4▲ 17×2 topics
- Biomedical Literature4▲ 58×1 topic
- Biomedical Ontologies4▲ 58×1 topic
- Interventions4▲ 12×3 topics
Which research topics does IQVIA (United States) publish most on?
By volume in 2022–2025: Health Systems, Economic Evaluations, Quality of Life, Pharmaceutical Economics and Policy, Economic and Financial Impacts of Cancer and Biomedical Text Mining and Ontologies.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 18 works
- 2 Pharmaceutical Economics and Policy Economics and Econometrics 6 works
- 3 Economic and Financial Impacts of Cancer Economics and Econometrics 5 works
- 4 Biomedical Text Mining and Ontologies Molecular Biology 4 works
- 5 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 4 works
- 6 Biosimilars and Bioanalytical Methods Immunology 4 works
- 7 CAR-T cell therapy research Oncology 3 works
- 8 Medication Adherence and Compliance Family Practice 3 works
- 9 Catalytic Cross-Coupling Reactions Organic Chemistry 2 works
- 10 Biomedical Ethics and Regulation Physiology 2 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has IQVIA (United States)'s research output changed?
Output in 2018–2022 was 25% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Durham
- Duke University
- Duke Medical Center
- Duke University Hospital
- Research Triangle Park Foundation
- National Institute of Environmental Health Sciences
- RTI International
- North Carolina Central University
- Durham VA Medical Center
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.